When should an insulin infusion be started in an adult critically ill patient with uncontrolled hyperglycemia (e.g., blood glucose ≥250 mg/dL with ketosis or ≥300 mg/dL in hyperosmolar hyperglycemic state)?

When to Start Insulin Infusion in Critically Ill Adults

Initiate a continuous intravenous insulin infusion when blood glucose reaches ≥180 mg/dL on two consecutive measurements in any critically ill adult patient, regardless of diabetes history, steroid use, or nutritional support. 1, 2, 3

Initiation Threshold

• Start IV insulin at ≥180 mg/dL (10 mmol/L) on two consecutive readings for all critically ill adults in the ICU, including medical, surgical, cardiac, neurologic, and post-operative patients. 1, 2, 3

• The 180 mg/dL trigger is intentionally set lower than the target range (140–180 mg/dL) to prevent prolonged exposure to harmful hyperglycemia that causes osmotic diuresis, endothelial dysfunction, immune impairment, and increased infection risk. 1, 2

• This threshold applies universally—whether the patient has pre-existing diabetes, is receiving high-dose corticosteroids, is on enteral/parenteral nutrition, or has anticipated short ICU stays. 2

Target Glucose Range After Starting Insulin

• Maintain blood glucose between 140–180 mg/dL for all critically ill adults once insulin therapy is initiated. 1, 2, 3

• Avoid intensive targets (80–139 mg/dL or <140 mg/dL) in unselected ICU populations—the NICE-SUGAR trial demonstrated that tight control increases mortality and severe hypoglycemia 10- to 15-fold without clinical benefit. 1, 2

• More stringent targets of 110–140 mg/dL may be considered only for highly selected post-cardiac surgery patients and only if achievable without significant hypoglycemia. 1, 2

Preferred Route: Continuous IV Insulin Infusion

• Use continuous intravenous regular insulin infusion as the preferred method for critically ill adults with hyperglycemia. 1, 2, 3

• The 2024 Society of Critical Care Medicine guidelines conditionally recommend IV insulin over intermittent subcutaneous insulin for acute hyperglycemia management in critically ill adults. 1, 2

• Never use subcutaneous insulin in hemodynamically unstable patients, during hypotension or shock—absorption is unpredictable and unreliable. 2, 3

Initial Insulin Dosing

• Start at 0.1 units/kg/hour of regular insulin via continuous IV infusion for most critically ill patients with hyperglycemia. 2, 3

• For severe hyperglycemia (>300 mg/dL) or diabetic ketoacidosis, consider an initial IV bolus of 0.15 units/kg before starting the continuous infusion. 3

• For non-DKA hyperglycemia, a loading bolus is optional and not universally required. 3

Monitoring Requirements

• Measure blood glucose every 1–2 hours during the initial phase of insulin infusion until glucose values and infusion rates stabilize. 1, 2, 3

• Once stable in the target range, continue monitoring every 2 hours. 1, 2

• During periods of glycemic instability, the 2024 SCCM guidelines recommend monitoring at ≤1-hour intervals or using continuous glucose monitoring when available. 1, 2

Protocol-Driven Care

• Use a validated insulin infusion protocol with explicit computerized clinical decision-support tools (or structured paper-based protocols) to guide titration and reduce hypoglycemia risk. 1, 2, 3

• Protocols must have demonstrated low hypoglycemia rates (<1% of measurements <70 mg/dL) in validation studies before implementation. 2, 3

• Protocols with decision-support tools improve glycemic control and lower hypoglycemia incidence compared with unstructured approaches. 1, 2

Before Starting Insulin: Evaluate Reversible Causes

• Assess and address modifiable factors before initiating insulin: dextrose-containing IV fluids, enteral/parenteral nutrition rates, and hyperglycemia-inducing medications (corticosteroids, vasopressors). 3

• Check serum potassium before starting insulin—do not initiate if potassium is <3.3 mEq/L; correct hypokalemia first, as insulin drives potassium intracellularly and can precipitate life-threatening hypokalemia. 3, 4

Special Considerations for Hyperglycemic Emergencies

Diabetic Ketoacidosis (DKA)

• For moderate to severe DKA, start continuous IV insulin at 0.1 units/kg/hour after an initial bolus of 0.15 units/kg. 5, 6, 7

• Do not delay insulin initiation in DKA—start IV insulin simultaneously with fluid resuscitation if significant ketosis is present (ketones ≥1.5 mmol/L or urine ketones ≥2+). 3, 5

Hyperosmolar Hyperglycemic State (HHS)

• In HHS without significant ketosis, start IV fluids first to restore circulating volume; delay insulin infusion until osmolality stops falling with fluid replacement alone unless ketonaemia is present. 5, 8

• If ketosis is present in HHS (mixed DKA/HHS), start insulin infusion at the same time as IV fluids. 5

• Target blood glucose of 10–15 mmol/L (180–270 mg/dL) in the first 24 hours of HHS treatment to allow gradual decline in osmolality (3.0–8.0 mOsm/kg/h) and minimize risk of cerebral edema. 5

Critical Pitfalls to Avoid

• Never rely on sliding-scale insulin alone as the primary regimen—it causes unacceptable glycemic variability, poor control, and increased complications. 1, 2, 3

• Do not target glucose <140 mg/dL in unselected critically ill patients—this increases mortality and severe hypoglycemia risk approximately four-fold without benefit. 1, 2

• Do not delay insulin initiation when glucose persistently exceeds 180 mg/dL—prolonged hyperglycemia causes progressive harm through osmotic diuresis, immune dysfunction, and infection risk. 1, 2

• Never abruptly stop IV insulin without overlapping subcutaneous basal insulin—this causes immediate loss of glucose control and rebound hyperglycemia. 3

• Avoid correcting glucose too rapidly (>50–75 mg/dL per hour)—this may cause neurological complications, particularly in HHS. 3

Hypoglycemia Management

• Establish a hypoglycemia management protocol before starting insulin therapy; treat any glucose ≤70 mg/dL immediately. 1, 2, 3

• Administer 15 g of fast-acting carbohydrate (or IV dextrose if NPO), recheck glucose in 15 minutes, and repeat treatment as needed. 3

• If hypoglycemia occurs without obvious cause, reduce the insulin infusion rate by 10–20% promptly. 3

Transition to Subcutaneous Insulin

• Give the first dose of subcutaneous basal insulin 1–2 hours before stopping the IV infusion to ensure adequate overlap and prevent rebound hyperglycemia. 3

• Calculate total daily subcutaneous insulin requirement as 80% of the total IV insulin used in the previous 24 hours. 3

• Only transition when the patient is hemodynamically stable, off vasopressors, peripheral edema has resolved, and nutritional intake is predictable. 3